Skip to main content
. 2018 May 19;10(5):1103–1132. doi: 10.18632/aging.101452

Table 2. Summary and evaluation of secreted miRNAs by qPCR panels.

  Preliminary screening Final screening
conditions Q SIPS Q SIPS
biological replicates (HDF) N = 1 N = 1 N = 3 N = 3
Time points (days post treatment) D21 D21 D7; D21 D7; D21
number of cells used for sEV-RNA (average) 1.27E+07 9.13E+05 1,50E+07 ± 33% 1,65E+06 ± 30%
screened miRNAs (Exiqon) 752 375
detected miRNAs in 2 conditions (average) 386 371
detected miRNAs in 1 condition (average) 156 0
not detected (average) 210 4
raw Ct-values normalized to number of cells used for sEV-RNA
detected miRNAs Ct(Average) ≤ 31 101 187 112 220
detected miRNAs Ct(Average) 31 - 35 197 142 138 132
detected miRNAs Ct(Average) 35 - 38 459 313 121 19
detected miRNAs Ct(Average) > 38 366 235 0 0
Dataset of miRNAs for statistic quantification (Ct(Average) < 38) 353
miRNAs with complete dataset for 3 Donor D7/D21 280/290
miRNAs with complete dataset for 2 Donor D7/D21 36/38
miRNAs with complete dataset for 1 Donor D7/D21 36/24

Preliminary screening of secreted miRNAs to determine detectable miRNAs in small EVs derived from HDFs, was performed using one HDF strain in both conditions, stress-induced premature senescent (SIPS) and quiescent control (Q), from one time point (D21). 375 miRNAs out of 752 screened were selected for the final screening with three different HDF cell strains (n = 3), in 2 conditions (SIPS and Q) and from two time points at 7 (D7) and 21 days (D21) after treatment.